Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 1.45 million shares were traded. BDTX stock price reached its highest trading level at $2.61 during the session, while it also had its lowest trading level at $2.48.
Ratios:
For a deeper understanding of Black Diamond Therapeutics Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.07 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.78. For the most recent quarter (mrq), Quick Ratio is recorded 8.94 and its Current Ratio is at 8.94. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.13.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 19 ’25 when BIOTECH GROWTH N V sold 5,784,292 shares for $2.07 per share. The transaction valued at 11,997,749 led to the insider holds 2,733,547 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BDTX now has a Market Capitalization of 144716272 and an Enterprise Value of 28883280. As of this moment, Black’s Price-to-Earnings (P/E) ratio for their current fiscal year is 7.00. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.07 while its Price-to-Book (P/B) ratio in mrq is 1.15. Its current Enterprise Value per Revenue stands at 0.413 whereas that against EBITDA is 1.907.
Stock Price History:
The Beta on a monthly basis for BDTX is 3.42, which has changed by 0.15981734 over the last 52 weeks, in comparison to a change of 0.14402747 over the same period for the S&P500. Over the past 52 weeks, BDTX has reached a high of $4.94, while it has fallen to a 52-week low of $1.20. The 50-Day Moving Average of the stock is -29.97%, while the 200-Day Moving Average is calculated to be -6.71%.
Shares Statistics:
For the past three months, BDTX has traded an average of 1.23M shares per day and 1060860 over the past ten days. A total of 56.94M shares are outstanding, with a floating share count of 44.75M. Insiders hold about 21.46% of the company’s shares, while institutions hold 58.80% stake in the company. Shares short for BDTX as of 1764288000 were 6123148 with a Short Ratio of 4.98, compared to 1761868800 on 6174621. Therefore, it implies a Short% of Shares Outstanding of 6123148 and a Short% of Float of 15.43.
Earnings Estimates
The market rating for Black Diamond Therapeutics Inc (BDTX) is a result of the insights provided by 6.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $0.06, with high estimates of $1.03 and low estimates of -$0.22.
Analysts are recommending an EPS of between $0.47 and $0.34 for the fiscal current year, implying an average EPS of $0.42. EPS for the following year is -$0.6, with 6.0 analysts recommending between -$0.19 and -$0.83.
